Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck - 18 Year Stock Price History | MKKGY

Historical daily share price chart and data for Merck since 2007 adjusted for splits and dividends. The latest closing stock price for Merck as of June 16, 2025 is 26.52.
  • The all-time high Merck stock closing price was 49.25 on December 31, 2021.
  • The Merck 52-week high stock price is 39.17, which is 47.7% above the current share price.
  • The Merck 52-week low stock price is 24.32, which is 8.3% below the current share price.
  • The average Merck stock price for the last 52 weeks is 31.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Merck Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 27.6829 28.1665 31.0941 23.9322 26.5200 -5.71%
2024 32.9853 30.1176 38.3544 28.0486 28.1272 -9.01%
2023 33.9983 37.0710 41.5891 28.3653 30.9114 -16.12%
2022 35.5116 47.6908 47.6908 28.8659 36.8513 -25.18%
2021 38.2224 32.9740 49.2506 28.7195 49.2506 53.08%
2020 24.5536 21.9827 32.1737 16.3550 32.1737 46.87%
2019 20.0693 18.7866 22.3645 17.8528 21.9069 15.68%
2018 18.7141 19.5181 20.7026 16.6919 18.9371 -1.98%
2017 20.1355 18.7840 24.2725 18.7273 19.3204 4.57%
2016 17.3304 16.4246 19.7558 14.2301 18.4752 8.35%
2015 17.7528 16.2324 20.4452 15.0669 17.0509 4.51%
2014 15.1092 15.0289 17.4056 13.2248 16.3158 6.05%
2013 13.1882 11.2442 15.3857 10.9329 15.3857 38.42%
2012 9.3049 8.5415 11.6514 7.5966 11.1153 34.60%
2011 7.7824 6.4963 9.4188 6.3062 8.2582 27.60%
2010 6.6931 7.4774 7.7590 5.6797 6.4720 -12.41%
2009 7.3161 7.2088 8.4600 5.5443 7.3888 4.88%
2008 8.9406 10.5838 11.4872 5.5490 7.0447 -26.74%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.047B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.271B 31.77
Zoetis (ZTS) United States $73.161B 27.31
Takeda Pharmaceutical (TAK) Japan $48.365B 9.54
Daiichi Sankyo, - (DSNKY) Japan $46.601B 23.51
BeOne Medicines - (ONC) Cayman Islands $29.540B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.150B 0.00
Summit Therapeutics (SMMT) United States $14.690B 0.00
Shionogi (SGIOY) Japan $14.547B 14.72
United Therapeutics (UTHR) United States $12.781B 11.51
Neurocrine Biosciences (NBIX) United States $12.310B 42.37
Orion OYJ (ORINY) Finland $10.212B 27.81
IPSEN (IPSEY) France $10.004B 0.00
Corcept Therapeutics (CORT) United States $7.429B 61.12
Stevanato Group S.p.A (STVN) Italy $7.111B 44.98
Madrigal Pharmaceuticals (MDGL) United States $6.563B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.664B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.975B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.870B 10.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.429B 13.75
NewAmsterdam Pharma (NAMS) Netherlands $2.269B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.000B 0.00
Indivior (INDV) United States $1.915B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $1.653B 0.00
Dyne Therapeutics (DYN) United States $1.638B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.512B 0.00
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.246B 0.00
Harrow (HROW) United States $1.112B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.105B 22.00
Enliven Therapeutics (ELVN) United States $1.075B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.15
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.926B 0.00
Ardelyx (ARDX) United States $0.861B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Elite Pharmaceuticals (ELTP) United States $0.718B 0.00
Xeris Biopharma Holdings (XERS) United States $0.680B 0.00
Xencor (XNCR) United States $0.654B 0.00
KalVista Pharmaceuticals (KALV) United States $0.644B 0.00
AleAnna (ANNA) United States $0.592B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Altimmune (ALT) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.550B 12.49
Verve Therapeutics (VERV) United States $0.549B 0.00
Bioventus (BVS) United States $0.544B 13.75
Theravance Biopharma (TBPH) United States $0.535B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.499B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.454B 9.70
Organogenesis (ORGO) United States $0.389B 0.00
Savara (SVRA) United States $0.382B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.87
Aquestive Therapeutics (AQST) United States $0.340B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 25.10
Nanobiotix S.A (NBTX) France $0.252B 0.00
ProKidney (PROK) United States $0.245B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
OmniAb (OABI) United States $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Aldeyra Therapeutics (ALDX) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.146B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 17.30
Fractyl Health (GUTS) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Wellgistics Health (WGRX) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Surrozen (SRZN) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 60.89
Inotiv (NOTV) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Klotho Neurosciences (KLTO) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
FibroGen (FGEN) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.17
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00